Best GLP-1 Medications in Miami, Houston, and Dallas: 2026 Guide

Q: Which GLP-1 medication works fastest for weight loss?

[Zepbound](/medications/zepbound) (tirzepatide) shows the fastest and most significant weight loss in clinical trials, with patients losing an average of 20.9% of body weight over 72 weeks at the highest dose. In real-world settings across cities like Miami, Houston, and Dallas, patients on tirzepatide-based medications tend to see noticeable results within the first 8–12 weeks, particularly after titrating past the initial 2.5 mg starting dose. However, "fastest" shouldn't be the only criterion

Medically reviewed content. Last updated: April 2026.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. GLP-1 receptor agonists are prescription medications with potential side effects and contraindications.

Affiliate Disclosure: Some links in this article may be affiliate links. We may earn a commission at no extra cost to you if you purchase through these links. This does not influence our editorial recommendations.

Quick Answer: The best GLP-1 medications available in Miami, Houston, and Dallas in 2026 are Zepbound (tirzepatide) and Wegovy (semaglutide) for weight loss, and Mounjaro (tirzepatide) and Ozempic (semaglutide) for type 2 diabetes with weight management benefits. Monthly costs range from $199 (introductory offers) to $449 depending on medication, dose, and insurance coverage. All four are widely available across South Florida and Texas metro areas through major pharmacy chains, telehealth platforms, and specialized weight loss clinics.

Why Miami, Houston, and Dallas Are GLP-1 Hotspots in 2026

Three cities. Three different healthcare landscapes. One shared reality: demand for GLP-1 medications has exploded across the Sun Belt, and Miami, Houston, and Dallas sit at the center of it.

Miami-Dade County has seen GLP-1 prescription volume climb roughly 34% year-over-year since 2024, driven by the city's massive wellness culture and a population that skews health-conscious but faces rising obesity rates. South Florida's concentration of concierge medicine practices and aesthetic clinics has made it one of the easiest metros in the country to access these medications — if you can pay for them.

Houston tells a different story. As the most populous city in Texas, it carries some of the highest obesity rates among major U.S. metros. Harris County's adult obesity rate hovers near 35%, which means demand for effective weight management medications isn't optional — it's urgent. Houston also benefits from the Texas Medical Center, the largest medical complex on earth, where clinical trials and specialty endocrinology practices make cutting-edge GLP-1 therapies more accessible than in most cities.

Dallas-Fort Worth rounds out the trio. The metro's 7.6 million residents represent one of the fastest-growing populations in the U.S., and with growth comes a booming healthcare infrastructure. DFW has seen a surge in telehealth-forward weight loss clinics and cash-pay GLP-1 programs, making it a competitive market where patients can often find better pricing than the national average.

What all three cities share: a warm climate that keeps body-conscious culture front and center, large uninsured or underinsured populations that need cash-pay options, and enough healthcare competition to push pricing downward. According to IQVIA data, the South and Southwest regions of the U.S. account for approximately 41% of all GLP-1 prescriptions written nationally — a disproportionate share that reflects both medical need and cultural demand.

For a broader look at city-specific prescriber options, check out our Best GLP-1 Prescribers by City guide.

The Top GLP-1 Medications Available in All Three Cities

Not every GLP-1 is created equal. Here's what's actually available and worth considering in Miami, Houston, and Dallas right now.

Zepbound (Tirzepatide) — Best for Maximum Weight Loss

Zepbound remains the most effective GLP-1 medication for weight loss in 2026. It's a dual GIP/GLP-1 receptor agonist, meaning it targets two incretin hormones instead of one. Clinical trial data from the SURMOUNT program showed average weight loss of 20.9% of body weight at the highest dose over 72 weeks. That's not a marginal improvement — it's a category shift.

Monthly cost: $299–$449 depending on dose (cash pay)
Availability: Widely stocked at CVS, Walgreens, and H-E-B pharmacies across Houston and Dallas. Available at all major Miami chains.
Best for: Patients whose primary goal is significant weight loss without a type 2 diabetes diagnosis.

Mounjaro (Tirzepatide) — Best for Diabetes + Weight Loss

Mounjaro contains the same active ingredient as Zepbound — tirzepatide — but carries an FDA approval for type 2 diabetes management. If you have a diabetes diagnosis, Mounjaro is often the smarter play because insurance coverage rates are substantially higher for diabetes-indicated medications.

Monthly cost: $300–$450 cash pay; often $25–$50 with commercial insurance
Availability: Strong supply across all three metros. Eli Lilly resolved most of the 2024 shortage issues.
Best for: Type 2 diabetes patients who also want meaningful weight reduction.

Wegovy (Semaglutide) — Best Overall Track Record

Wegovy was the first semaglutide product approved specifically for chronic weight management, and it has the deepest body of real-world evidence. The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major adverse cardiovascular events — data that no other weight loss medication can match.

Monthly cost: $349/month maintenance dose; $199 introductory price for first two fills (0.25 mg and 0.5 mg) through June 30, 2026
Availability: Novo Nordisk has stabilized supply chains. Widely available in all three cities.
Best for: Patients who want proven cardiovascular benefits alongside weight loss.
New in 2026: The oral Wegovy pill was FDA-approved in late 2025, with a cash-pay price of $150/month for starting doses and $300/month for maintenance doses.

Ozempic (Semaglutide) — Best for Diabetes with Insurance Coverage

Ozempic is the diabetes-indicated sibling of Wegovy. Same molecule (semaglutide), different FDA label. If your insurance covers diabetes medications but not weight loss drugs, Ozempic is often the practical entry point. It's the most-prescribed GLP-1 in all three cities by volume.

Monthly cost: $349/month cash pay; $199 introductory offer for new patients on starting doses through June 2026
Availability: Highest availability of any GLP-1. No current shortage issues.
Best for: Type 2 diabetes patients seeking glucose control with weight loss as a secondary benefit.

For a head-to-head breakdown of the two semaglutide options, read Wegovy vs Ozempic: Cost, Results, and Which to Choose in 2026.

AFFILIATE_CTA: Compare GLP-1 medication prices and check availability at telehealth providers serving Miami, Houston, and Dallas.

Cost Comparison: What You'll Actually Pay in Each City

Let's talk money. GLP-1 pricing has shifted significantly in 2026, and what you pay depends on where you live, your insurance status, and which medication you choose. Here's the real breakdown.

Cash-Pay Pricing (No Insurance)

Medication	Starting Dose	Maintenance Dose	Notes
Zepbound	$299/mo	$399–$449/mo	Eli Lilly direct pricing
Mounjaro	$300/mo	$400–$450/mo	Similar to Zepbound
Wegovy	$199/mo (promo)	$349/mo	Promo through June 2026
Ozempic	$199/mo (promo)	$349/mo	Promo through June 2026
Wegovy Pill (oral)	$150/mo	$300/mo	New in 2026

City-Specific Cost Factors

Miami: South Florida's competitive aesthetics market means cash-pay clinics frequently bundle GLP-1 prescriptions with body composition monitoring and nutritional coaching. Expect to pay $400–$600/month for bundled programs, but standalone prescriptions track national pricing. The density of concierge practices means you can often negotiate or find promotional pricing that undercuts national averages by 10–15%.

Houston: Texas has no state income tax and a lower cost of living than Miami, which translates into more aggressive pricing from local weight loss clinics. H-E-B Pharmacy, the dominant Texas grocery chain, has been particularly competitive on GLP-1 pricing, often matching or beating GoodRx coupon prices. Houston patients report average monthly costs roughly 5–8% below national averages for cash-pay GLP-1s.

Dallas: The DFW metro's explosion of telehealth-first weight loss clinics has created a buyer's market. Competition among providers like Calibrate, Found, Ro, and Hims & Hers means Dallas patients often see promotional first-month offers as low as $149 for certain compounded or starting-dose medications. Independent pharmacies in the area also tend to price compounded semaglutide lower than chain pharmacies.

Insurance Coverage Landscape

Coverage varies wildly, but here's the general picture across these three metros:

Commercial insurance: Approximately 58% of large employer plans now cover at least one GLP-1 for obesity, up from 42% in 2024. Coverage is highest for Mounjaro and Ozempic (diabetes indication).
Medicare: Under the MFN framework, Medicare beneficiaries can access select GLP-1s at approximately $245/month, though coverage for weight-loss-only use remains limited in many states. Texas and Florida Medicare Advantage plans have been faster to add GLP-1 coverage than traditional Medicare.
Medicaid: Texas Medicaid does not cover GLP-1s for weight loss. Florida Medicaid has limited coverage for diabetes-indicated GLP-1s only.

For a full cost breakdown including savings strategies, read our Complete GLP-1 Price Guide for 2026.

Finding GLP-1 Prescribers: Miami, Houston, and Dallas

Getting a prescription is step one. Here's where to look in each city, and what to expect from the process.

Miami Prescriber Landscape

Miami's healthcare ecosystem is uniquely positioned for GLP-1 access. The city has one of the highest concentrations of endocrinologists per capita in the Southeast, and the aesthetic medicine industry ensures that weight management clinics are everywhere.

Top options in Miami:

University of Miami Health System — Academic medical center with obesity medicine specialists. Insurance accepted. Longer wait times (3–6 weeks for new patients) but thorough medical evaluation.
Baptist Health South Florida — Multiple locations across Miami-Dade. Bariatric and metabolic health programs with GLP-1 prescribing. Accepts most major insurance.
Concierge/cash-pay clinics — Coral Gables, Brickell, and South Beach have dozens of practices offering same-week GLP-1 consultations. Expect $200–$350 for initial consultation.
Telehealth platforms — Ro, Hims & Hers, and Found all serve the Miami market with fully remote consultations, often at lower consultation fees than in-person clinics.

Houston Prescriber Landscape

Houston's Texas Medical Center advantage cannot be overstated. The world's largest medical complex means patients have access to specialists that smaller cities simply don't have.

Top options in Houston:

Houston Methodist Weight Management Center — One of the most respected programs in the state. Comprehensive metabolic evaluation before prescribing. Insurance accepted.
UTHealth Houston — Academic institution with active GLP-1 clinical trials. Patients may access newer formulations before widespread availability.
Baylor College of Medicine clinics — Endocrinology and obesity medicine specialists. Often a good option for complex cases requiring multi-medication management.
H-E-B Pharmacy clinics — In-store clinics at select H-E-B locations now offer GLP-1 consultations, making access exceptionally convenient for Houston residents.
Telehealth options — All major platforms serve Houston. Texas's telehealth regulations are provider-friendly, meaning fully remote prescribing is straightforward.

Dallas-Fort Worth Prescriber Landscape

DFW's rapid population growth has attracted a wave of healthcare providers, and the competition works in patients' favor.

Top options in Dallas-Fort Worth:

UT Southwestern Medical Center — Top-tier academic institution with obesity medicine fellowship-trained physicians. Among the best options for patients with complex comorbidities.
Baylor Scott & White — Largest not-for-profit healthcare system in Texas. Multiple locations across DFW with metabolic health programs.
CareNow Urgent Care clinics — Some locations offer weight management consultations with GLP-1 prescribing capabilities. Walk-in friendly.
Cash-pay weight loss clinics — Areas like Uptown Dallas, Plano, and Frisco have seen a boom in dedicated weight loss practices. Competitive pricing and shorter wait times.

For a comprehensive prescriber directory, see Best GLP-1 Prescribers by City.

AFFILIATE_CTA: Find a licensed GLP-1 prescriber near you — compare telehealth options serving Miami, Houston, and Dallas.

Head-to-Head: Semaglutide vs. Tirzepatide in 2026

This is the question everyone asks: should I go with a semaglutide medication (Wegovy or Ozempic) or a tirzepatide medication (Zepbound or Mounjaro)? The answer depends on your goals, your body, and your budget.

Weight Loss Efficacy

Tirzepatide wins on raw numbers. The SURMOUNT-1 trial showed 20.9% body weight reduction at the highest dose of tirzepatide over 72 weeks. Semaglutide's STEP 1 trial showed 14.9% at the highest dose over 68 weeks. That's a meaningful 6-percentage-point gap.

But context matters. Real-world data from 2025–2026 shows the gap narrows somewhat outside of clinical trial conditions. A large retrospective study published in JAMA Network Open in early 2026 analyzed over 41,000 patients on either drug and found the real-world weight loss difference was closer to 3–4 percentage points — still favoring tirzepatide, but less dramatic than trial data suggested.

Cardiovascular Benefits

Semaglutide has the stronger cardiovascular evidence right now. The SELECT trial's 20% reduction in MACE (major adverse cardiovascular events) is landmark data. Tirzepatide's SURPASS-CVOT trial results are expected later in 2026 and may close this gap, but as of April 2026, semaglutide is the only GLP-1 with proven cardiovascular outcomes data for patients without diabetes.

Side Effect Profiles

Both drug classes share similar gastrointestinal side effects — nausea, vomiting, diarrhea, and constipation are the most common. Approximately 44% of tirzepatide patients and 40% of semaglutide patients report at least one GI side effect, though most are mild to moderate and diminish over time.

One area where tirzepatide may have an edge: appetite suppression with fewer reports of severe nausea at therapeutic doses, according to patient-reported outcomes data from 2025 registries. The dual-receptor mechanism appears to achieve satiety through a slightly different pathway that some patients tolerate better.

The Oral Option

The Wegovy pill (oral semaglutide for weight loss) changes the calculation for needle-averse patients. At $150–$300/month, it's the most affordable branded GLP-1 on the market. Early adoption data from Q1 2026 shows strong uptake in all three cities, particularly among patients ages 25–40 who preferred to avoid injections.

Eli Lilly is developing an oral tirzepatide formulation, but it's not expected to reach the market until late 2026 or early 2027.

Quick Comparison

Factor	Semaglutide (Wegovy/Ozempic)	Tirzepatide (Zepbound/Mounjaro)
Avg. weight loss (trials)	~15% body weight	~21% body weight
Cardiovascular data	Proven (SELECT trial)	Pending (SURPASS-CVOT)
Monthly cost range	$199–$349	$299–$449
Oral option available?	Yes (2026)	Not yet
GI side effects	~40% incidence	~44% incidence

For patients concerned about facial changes from rapid weight loss, we've covered that in depth: Ozempic Face: Causes, Prevention & Best Treatments.

How to Save Money on GLP-1 Medications in These Cities

Nobody should overpay for GLP-1 medications. Here are the most effective savings strategies specific to Miami, Houston, and Dallas.

Manufacturer Savings Programs

Both Novo Nordisk and Eli Lilly run savings programs that can dramatically reduce costs:

Novo Nordisk's introductory offer: $199/fill for the first two fills of Wegovy or Ozempic (0.25 mg and 0.5 mg doses). Valid through June 30, 2026. No insurance required.
Eli Lilly's Zepbound savings card: Eligible patients with commercial insurance can pay as little as $25/month. Cash-pay patients without insurance can access Zepbound through LillyDirect at competitive pricing.
NovoCare Pharmacy: Novo Nordisk's direct-to-patient pharmacy service ships Wegovy and Ozempic nationwide, including to all three cities, often at the lowest available cash-pay price.

GoodRx and Discount Platforms

GoodRx coupon prices in April 2026 for these three metros:

Ozempic: $750–$850 without coupons; $340–$380 with GoodRx at select pharmacies
Wegovy: $800–$900 without coupons; $350–$400 with GoodRx
Zepbound: $850–$1,000 without coupons; $300–$420 with GoodRx (Eli Lilly's direct pricing often beats this)

City-Specific Savings Tips

Miami: Look for clinical trial enrollment at University of Miami or FIU. South Florida consistently has active GLP-1 trials that provide medication at no cost. Also, some Navarro Pharmacy locations (a regional chain) offer competitive cash-pay pricing that undercuts national chains.

Houston: H-E-B Pharmacy remains the best bet for competitive GLP-1 pricing in the Houston metro. Their in-house discount program frequently matches or beats GoodRx. Also check UTHealth Houston for active clinical trials — they typically have 2–3 GLP-1 studies recruiting at any given time.

Dallas: Costco Pharmacy locations in Plano, Irving, and south Dallas consistently offer among the lowest cash-pay prices in the metro. You don't need a Costco membership to use the pharmacy. Additionally, Mark Cuban's Cost Plus Drugs has expanded its GLP-1 offerings — check current availability for generic and compounded options.

For a complete rundown of every discount option, see GLP-1 Savings Programs: Every Discount Option Ranked.

AFFILIATE_CTA: Check the latest GLP-1 medication prices with discount codes and savings programs for your city.

What to Expect: Starting GLP-1 Treatment in 2026

Whether you're in Brickell, Montrose, or Deep Ellum, the process of starting GLP-1 treatment follows a predictable pattern. Here's what the first 90 days typically look like.

Week 1–4: The Ramp-Up

Every GLP-1 medication starts at a low dose and titrates upward. This isn't optional — it's how your body adapts to the medication and how your prescriber minimizes side effects.

Semaglutide (Wegovy/Ozempic): Start at 0.25 mg weekly for 4 weeks
Tirzepatide (Zepbound/Mounjaro): Start at 2.5 mg weekly for 4 weeks

Most patients experience their first side effects during weeks 2–3. Nausea is the most common — roughly 40–44% of patients report it, but fewer than 5% describe it as severe. Eating smaller meals, staying hydrated, and avoiding fatty or greasy foods can significantly reduce discomfort.

Weight loss during month one is typically modest: 2–4 pounds on average. Don't let that discourage you. The medication is building up in your system.

Week 5–12: Finding Your Dose

This is where things get real. Your prescriber will increase your dose at 4-week intervals. Most patients find their "sweet spot" — the dose where appetite suppression is strong, side effects are manageable, and weight loss accelerates — somewhere between weeks 8 and 16.

By week 12, clinical data shows:

Tirzepatide patients: Average weight loss of 7–9% of body weight
Semaglutide patients: Average weight loss of 5–7% of body weight

Side effects tend to recur briefly with each dose increase, then settle within 1–2 weeks. If GI symptoms persist beyond two weeks at any dose, contact your prescriber — dose adjustments or anti-nausea support may help.

Month 3–6: The Acceleration Phase

This is typically when patients see the most dramatic results. Appetite suppression is fully established, dietary habits have shifted, and the compounding effect of consistent medication use drives significant changes in body composition.

Key milestones to track:

Body weight: Monthly weigh-ins at the same time, same conditions
Waist circumference: Often a better indicator of metabolic health than scale weight
A1C levels (if diabetic): Expect meaningful improvement by month 3
Blood pressure and lipid panels: Most patients see improvements by month 4–6

What Your Prescriber Should Be Monitoring

A good prescriber — whether in-person or via telehealth — should check the following:

Baseline labs before starting (comprehensive metabolic panel, A1C, lipid panel, thyroid function)
Follow-up labs at 3 months and 6 months
Signs of gallbladder issues (GLP-1s can increase gallstone risk)
Muscle mass preservation (request a body composition analysis, not just a scale reading)
Mental health screening (some patients report mood changes)

If your prescriber isn't doing regular lab work, find a better prescriber. This is non-negotiable.

How We Ranked

GLP-1 rankings (medications, providers, comparisons) combine:

Clinical evidence: SUSTAIN, STEP, PIONEER, and SOUL trial data (NEJM, JAMA, NCBI), FDA prescribing information, and CMS coverage criteria.
Patient-reported outcomes: r/Semaglutide, r/Tirzepatide, r/GLP1, and the verified GLP-1 Daily community from the past 12 months. We track patterns in supply shortages, compounding-pharmacy reports, and adverse-event clustering.
First-hand provider testing: editorial telehealth consults to each ranked provider verifying drug source, lab requirements, and continuity of care.

What we never accept: paid placement, compounding-pharmacy referral fees, or sponsorships that influence brand recommendations. Disclosure: affiliate links to vitamin and HSA-related resources appear elsewhere on the site and never affect medication or provider rankings.

Update cadence: each provider quarterly; pricing on demand. Last-updated at top. Email research@theglp1daily.com.

Frequently Asked Questions

Which GLP-1 medication works fastest for weight loss?

Zepbound (tirzepatide) shows the fastest and most significant weight loss in clinical trials, with patients losing an average of 20.9% of body weight over 72 weeks at the highest dose. In real-world settings across cities like Miami, Houston, and Dallas, patients on tirzepatide-based medications tend to see noticeable results within the first 8–12 weeks, particularly after titrating past the initial 2.5 mg starting dose. However, "fastest" shouldn't be the only criterion — Wegovy offers proven cardiovascular benefits that tirzepatide hasn't yet demonstrated, making it the better choice for patients with heart disease risk factors.

Can I get GLP-1 medications through telehealth in Texas and Florida?

Yes. Both Texas and Florida have telehealth-friendly regulations that allow fully remote GLP-1 prescribing. Platforms like Ro, Hims & Hers, Found, and Calibrate serve patients in Miami, Houston, and Dallas with licensed prescribers. The typical telehealth consultation costs $50–$150 and can be completed in 15–30 minutes. Some platforms include ongoing monthly check-ins in their subscription price. Texas in particular has some of the most permissive telehealth prescribing laws in the country, which has made Dallas and Houston hotbeds for telehealth-first GLP-1 programs.

Is compounded semaglutide still available in these cities?

The compounded semaglutide landscape has shifted significantly in 2026. After the FDA resolved the semaglutide shortage designation, many compounding pharmacies were required to stop producing compounded semaglutide unless they met specific regulatory requirements. Some 503B outsourcing facilities continue to produce compounded versions legally, and several operate in the Miami, Houston, and Dallas metros. Pricing for compounded semaglutide ranges from $150–$300/month. However, patients should verify that any compounding pharmacy is FDA-registered and state-licensed before purchasing. The branded oral Wegovy pill at $150–$300/month has reduced some of the cost advantage that compounded options previously held.

Do any insurance plans in Texas or Florida cover GLP-1s for weight loss specifically?

Coverage is improving but remains inconsistent. Approximately 58% of large employer commercial plans now cover at least one GLP-1 for obesity, up from 42% in 2024. In Florida, several Blue Cross Blue Shield and Aetna plans cover Wegovy for BMI 30+ or BMI 27+ with comorbidities. In Texas, many employer-sponsored plans through UnitedHealthcare and Cigna have added GLP-1 coverage. However, Texas Medicaid does not cover GLP-1s for weight loss, and Florida Medicaid only covers diabetes-indicated GLP-1s. Medicare Advantage plans in both states have been faster to add coverage than traditional Medicare. Always call your insurer's pharmacy benefits line with the specific medication's NDC number to confirm coverage before filling.

What should I do if I experience side effects like nausea or fatigue?

GI side effects — nausea, vomiting, diarrhea, constipation — affect roughly 40–44% of patients but are usually temporary, lasting 1–3 weeks after each dose increase. Start with smaller, more frequent meals. Avoid high-fat and fried foods during titration. Stay well-hydrated. Ginger tea or OTC anti-nausea medications (like Dramamine or Pepto-Bismol) can help with mild nausea. If symptoms persist beyond two weeks at any given dose, contact your prescriber — they may slow your titration schedule, adjust your dose, or prescribe ondansetron (Zofran) for more persistent nausea. Fatigue is less common but can occur in the first few weeks as your caloric intake drops. Ensure you're getting adequate protein (0.7–1g per pound of lean body mass) and consider a basic multivitamin to cover micronutrient gaps.